ディヒドロ葉酸還元酵素における酵素運動に対する突然変異の効果
James B Watney1, Pratul K Agarwal, Sharon Hammes-Schiffer
1Department of Chemistry, 152 Davey Laboratory, Pennsylvania State University, University Park 16802, USA.
Journal of the American Chemical Society
|March 27, 2003
まとめ
Escherichia coliの二酸化水素葉酸還元酵素 (重要な酵素) の Gly-121 からバリンへの変異は,ヒドリドの移転を著しく遅らせます. シミュレーションによると,これはより高い自由エネルギーバリアが原因で,タンパク質工学と薬剤設計に影響を及ぼしています.
科学分野:
- バイオケミストリー バイオケミストリー
- コンピュータ生物学 コンピュータ生物学
- エンジム・キネティクス
背景:
- ディヒドロフォラート還元酵素 (DHFR) は,生物学的システムにおける重要な酵素である.
- Escherichia coli DHFR の特定の変異 (Gly-121 から valine への変異) は,ヒドリド移転率を劇的に低下させます.
- この速度減少の分子基礎を理解することは,タンパク質工学と薬剤設計にとって不可欠です.
研究 の 目的:
- E. coli DHFR.のG121V変異体における減少した水素移転率の背後にある分子メカニズムを調査する.
- G121V変異が,水化物伝達の自由エネルギーバリアに与える影響を計算的に評価する.
- DHFR触媒におけるタンパク質ダイナミクスの役割を調査する.
主な方法:
- ハイブリッド量子-古典分子ダイナミクスシミュレーションが採用されました.
- ハイドリド移転のための自由エネルギーバリアは,野生型および変異型酵素の両方のために計算されました.
- トランスミッション係数は,転送プロセスの効率を分析するために計算されました.
主要な成果:
- シミュレーションにより,G121V変異がヒドリド移転のための自由エネルギーバリアを増やすことが確認されました.
- 自由エネルギーバリアの計算された増加は,レート減少の実験的観測と一致しています.
- 野生型酵素と変異型酵素の伝播係数は類似しており,バリアの高さが主な要因であることを示唆しています.
結論:
- E. coliのG121V変異は,自由エネルギーバリアを増加させ,触媒を阻害する.
- この変異は,DHFRの触媒機能に不可欠な運動を促進するネットワークを乱す可能性があります.
- この発見は,酵素工学と新しい治療法の開発に関する洞察を提供します.
さらに関連する動画
関連する概念動画
00:46Feedback Inhibition
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
01:08Allosteric Regulation
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
02:34Enzymes
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
01:48ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...